A&K Robotics was founded on a shared belief that robotic technologies has the potential to drastically improve Their world and quality of life. They see the future with unique eyes, pushing the boundaries of robotics and seeking real-life applications of new technologies.
Able Innovations is developing fully automated patient transfer technology to reduce labour and injury costs and improve efficiency, dignity, and quality of life for clients and caregivers alike. Our autonomous and intelligent transfer devices will be able to lift and transfer humans in a safe, efficient, and dignified manner, with zero physical effort required from caregivers. By performing safe and effortless automated transfers, our technology will help to reduce the $30 billion annual financial burden to healthcare facilities that result from the high injury rates and labour expenditure resulting from the inefficient, unsafe, and outdated patient transfer devices in use today. Our first product, the DELTA Platform, will leverage our unique transfer method to perform automated lateral transfers in hospitals and other healthcare facilities, allowing these facilities to save millions on injury costs and optimize their labour resources to achieve the greatest clinical and social outcomes for their clients. Using this same core transfer technology, we plan to develop intelligent and robust mobility devices for long-term care and homecare use, which will enable individuals with impaired mobility to live their lives with a hereto unprecedented level of dignity and independence.
Acerta’s machine learning and artificial intelligence-powered solutions are transforming quality control for precision manufacturers of parts built for automotive and off-highway vehicles. Acerta translates complex product data into actionable insights for manufacturers, helping them get products to market faster with fewer defects. Through this “Actionable AI,” Acerta’s ML/AI solutions help manufacturers locate the earliest indicators of future product failures, accelerate root cause analysis, reduce scrap and rework, and improve throughput. Their customers can make the right decisions fast, optimize production and improve product quality, ultimately improving profits.
The best anti-aging resource is your own younger cells. Personalized regenerative medicine is the opportunity to leverage strategies that tap into the power of our own cells to treat our bodies. Our cells have the potential to rejuvenate skin, replenish hair, and even help fight disease. Preserving your own cells today can give you access to your own younger cells to use in revolutionary treatments for the rest of your life.
Acrylic is a pre-seed art-tech startup and robotics company designing a new way to digitize the consumer art industry and manufacture fine art at scale. We’re driven by our goal of making art accessible for all and empowering artists to keep creating, and we’re currently developing the technical infrastructure required to collect, analyze and transform painting data and create painted reproductions through robotic automation. We offer artists a comprehensive sales management, manufacturing and fulfillment service that allows them to focus on creating new designs.
The AdHash Protocol cuts out the ad tech middlemen from the digital ad supply chain to create a more transparent, efficient, and privacy-focused marketplace. AdHash rebuilds the real-time bidding framework from the ground up, introducing direct ad serving and first-party data to advertisers and publishers while giving users control over their privacy and browsing experience.
Founded by two Harvard alumni and backed by General Catalyst, Alariss is the best way to hire business talent in the US. We empower tech companies to quickly and effectively build their remote US sales and business development teams by matching them with highly-trained professionals with elite networks and industry experiences. Our clients are top international tech companies in SaaS, IT, EdTech, and e-commerce such as Tencent, Xiaomi, and Bytedance. The Alariss sales methodology was developed by our founders’ experiences as Head of Sales for one of the most valuable YC companies of all time and as a US diplomat.